Statistics for Amphastar Pharmaceuticals (id:7585 AMPH)

Valuation metrics

Market cap

2.14B

Enterprise value

2.52B

Trailing P/E (ttm)

14.82

Forward P/E

10.21

PEG ratio

10.21

Price/Sales (ttm)

2.96

Price/Book (mrq)

2.97

Enterprise Value/Revenue

3.49

Enterprise Value/EBITDA

9.47

Overview

Shares outstanding

48.08M

Float

37.10M

Shares short

4.34M

% Held by insiders

0.22%

% Held by institutions

0.75%

Average volume (10 days)

511.75K

Average volume (90 days)

Price summary

52-Week low

36.56

52-Week high

65.92

52-Week change

-28.99%

Beta

0.82

50-Day moving average

48.40

200-Day moving average

44.92

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

21.80%

Operating margin

29.83%

Operational effectiveness

Return on assets

8.67%

Return on equity

23.85%

Income statement

Revenue (ttm)

14.94

Revenue per share (ttm)

14.94

Quarterly revenue growth (yoy)

-0.18

Gross profit (ttm)

351.12M

EBITDA

276.85M

Net income to common (ttm)

157.72M

Diluted EPS (ttm)

3.01

Quarterly earnings growth (yoy)

-17.90%

Balance sheet

Total cash (mrq)

250.49M

Total cash per share (mrq)

5.21

Total debt (mrq)

629.85M

Total Debt/Equity (mrq)

86.56

Current ratio (mrq)

343.30%

Book value per share (mrq)

15.04

Cash flow

Cash flow statement

208.23M

Levered free cash flow (LFCF)

8.61M